According to TipRanks.com, Divan is a 5-star analyst with an average return of 10.7% and a 57.1% success rate. Divan covers the Healthcare sector, focusing on stocks such as Unicycive Therapeutics, ...

Seasoned executive with extensive board experience across US and European biotechnology companies -- Brings extensive operational, strategic and transactional expertise as AstronauTx advances its ...

A live webcast of the presentation will be available under the “Events” page within the Investors section of Sionna’s website ...

After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease ...